Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials

[1]  J. Dyerberg,et al.  The composition of food consumed by Greenland Eskimos. , 2009, Acta medica Scandinavica.

[2]  J. Dyerberg,et al.  Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. , 2009, Acta medica Scandinavica.

[3]  M. Dorgan,et al.  Effect of fish oil on arrhythmias and mortality: systematic review , 2008, BMJ : British Medical Journal.

[4]  M. Burr,et al.  Heterogeneity in Randomized Controlled Trials of Long Chain (Fish) Omega-3 Fatty Acids in Restenosis, Secondary Prevention and Ventricular Arrhythmias , 2008, Journal of the American College of Nutrition.

[5]  J. Beyene,et al.  Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis , 2008, Canadian Medical Association Journal.

[6]  Y. Matsuzawa,et al.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.

[7]  Ethan M Balk,et al.  n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. , 2006, The American journal of clinical nutrition.

[8]  R. Hauer,et al.  Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. , 2006, JAMA.

[9]  Julian P T Higgins,et al.  Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review , 2006, BMJ : British Medical Journal.

[10]  J. Lau,et al.  Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review. , 2006, Atherosclerosis.

[11]  C. Niesler,et al.  Long-chain polyunsaturated fatty acids protect the heart against ischemia/reperfusion-induced injury via a MAPK dependent pathway. , 2005, Journal of molecular and cellular cardiology.

[12]  M. Josephson,et al.  Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake , 2005, Circulation.

[13]  Douglas G Altman,et al.  Bayesian random effects meta‐analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales by D. E. Warn, S. G. Thompson and D. J. Spiegelhalter, Statistics in Medicine 2002; 21: 1601–1623 , 2005, Statistics in medicine.

[14]  J. Mann.  The Indo-Mediterranean diet revisited , 2005, The Lancet.

[15]  R. Horton.  Expression of concern: Indo-Mediterranean Diet Heart Study , 2005, The Lancet.

[16]  Caroline White,et al.  Suspected research fraud: difficulties of getting at the truth , 2005, BMJ : British Medical Journal.

[17]  D. Sigg,et al.  The Antiarrhythmic Effect of n-3 Polyunsaturated Fatty Acids: Modulation of Cardiac Ion Channels as a Potential Mechanism , 2005, The Journal of Membrane Biology.

[18]  S. Chugh,et al.  Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. , 2005, JAMA.

[19]  C. Pandozi,et al.  N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. , 2005, Journal of the American College of Cardiology.

[20]  B. Abhyankar,et al.  The mechanism of action of omega-3 fatty acids in secondary prevention post-myocardial infarction , 2005, Current medical research and opinion.

[21]  D. Mozaffarian,et al.  Interplay Between Different Polyunsaturated Fatty Acids and Risk of Coronary Heart Disease in Men , 2005, Circulation.

[22]  H. Worthington,et al.  Omega 3 fatty acids for prevention and treatment of cardiovascular disease. , 2004, The Cochrane database of systematic reviews.

[23]  M. Lièvre,et al.  Fish oils in the care of coronary heart disease patients: a meta‐analysis of randomized controlled trials , 2004, Fundamental & clinical pharmacology.

[24]  A. Geelen,et al.  Antiarrhythmic effects of n-3 fatty acids: evidence from human studies , 2004, Current opinion in lipidology.

[25]  David E Newby,et al.  Edinburgh Research Explorer Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment , 2003 .

[26]  D. Mozaffarian,et al.  Cardiac Benefits of Fish Consumption May Depend on the Type of Fish Meal Consumed: The Cardiovascular Health Study , 2003, Circulation.

[27]  P. Elwood,et al.  Lack of benefit of dietary advice to men with angina: results of a controlled trial , 2003, European Journal of Clinical Nutrition.

[28]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[29]  R. de Caterina,et al.  Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis ITalian Study (ESPRIT). , 2002, American heart journal.

[30]  M. Santini,et al.  Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002, Circulation.

[31]  C. Schindler,et al.  N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. , 2002, The American journal of medicine.

[32]  M. Yu,et al.  Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. , 2001, American journal of epidemiology.

[33]  G. Albrektsen,et al.  Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. , 2001, The American journal of clinical nutrition.

[34]  P. Durrington,et al.  An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia , 2001, Heart.

[35]  I. Olkin,et al.  Improving the quality of reports of meta‐analyses of randomised controlled trials: the QUOROM statement , 2000, Revista espanola de salud publica.

[36]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[37]  H. Arnesen,et al.  n-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study , 1999 .

[38]  K. Theisen,et al.  The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. , 1999, Annals of internal medicine.

[39]  V. Rastogi,et al.  Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival—4 , 1997, Cardiovascular Drugs and Therapy.

[40]  H. Parving,et al.  Fish Oil in Diabetic Nephropathy , 1996, Diabetes Care.

[41]  J. Cairns,et al.  Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. , 1996, Circulation.

[42]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[43]  P. Stone,et al.  Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. , 1995, Journal of the American College of Cardiology.

[44]  A. Jacobs,et al.  Do fish oils prevent restenosis after coronary angioplasty? , 1994, Circulation.

[45]  H. Höpp,et al.  A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA. , 1993, Catheterization and cardiovascular diagnosis.

[46]  D. Ramsdale,et al.  Can supplementation of diet with omega-3 polyunsaturated fatty acids reduce coronary angioplasty restenosis rate? , 1992, European heart journal.

[47]  U. Kaul,et al.  Fish oil supplements for prevention of restenosis after coronary angioplasty. , 1992, International journal of cardiology.

[48]  I. Bairati,et al.  Double‐Blind, Randomized, Controlled Trial of Fish Oil Supplements in Prevention of Recurrence of Stenosis After Coronary Angioplasty , 1992, Circulation.

[49]  J. Nettleton,et al.  Omega-3 fatty acids: comparison of plant and seafood sources in human nutrition. , 1991, Journal of the American Dietetic Association.

[50]  M. Robertson,et al.  Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty. , 1990, Australian and New Zealand journal of medicine.

[51]  P. Elwood,et al.  EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.

[52]  A. Pichard,et al.  Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty. , 1989, The American journal of cardiology.

[53]  F. Sacks,et al.  RANDOMISED TRIAL OF FISH OIL FOR PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY , 1989, The Lancet.

[54]  J. Hopper,et al.  Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. , 1989, Journal of the American College of Cardiology.

[55]  J. Popma,et al.  Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. , 1988, The New England journal of medicine.

[56]  H. Sewell,et al.  CYTOCHROME P-450 IMMUNOLOCALISATION IN HUMAN LIVER , 1986, The Lancet.

[57]  Diana Brahams,et al.  Confidentiality and under-age girls who seek contraceptive advice. , 1983, Lancet.

[58]  C. Borchgrevink,et al.  Absence of prophylactic effect of linolenic acid in patients with coronary heart-disease. , 1966, Lancet.

[59]  M. Marshall.  ABNORMALITIES IN HUMAN SEX-CHROMOSOMES. , 1964, Lancet.

[60]  King Cg.  Advances in nutrition research. , 1955 .

[61]  L. Tavazzi,et al.  ect of n-3 polyunsaturated fatty acids in patients with chronic heart failure ( the GISSI-HF trial ) : a randomised , double-blind , placebo-controlled trial , 1980 .

[62]  S. Yusuf,et al.  Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). , 2008, American heart journal.

[63]  Cañada.  Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention) , 2008 .

[64]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[65]  W. Connor,et al.  Importance of n-3 fatty acids in health and disease. , 2000, The American journal of clinical nutrition.

[66]  ichard,et al.  FISH CONSUMPTION AND THE 30-YEAR RISK OF FATAL MYOCARDIAL INFARCTION , 2000 .

[67]  H. Arnesen,et al.  N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. , 1999, Journal of the American College of Cardiology.

[68]  K. Grønseth,et al.  Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. , 1996, The American journal of cardiology.

[69]  T. Dolecek,et al.  Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). , 1991, World review of nutrition and dietetics.

[70]  J. Dyerberg,et al.  Lipid Metabolism and Ischemic Heart Disease in Greenland Eskimos , 1980 .